Epidemiologic studies of estrogen metabolism and breast cancer

Steroids

Volumn 99, Issue Part A, 2015, Pages 67-75

  Ziegler, Regina G ^a   Fuhrman, Barbara J ^a   Moore, Steven C ^a   Matthews, Charles E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

16 hydroxyestrone; 2 hydroxyestrone; Breast cancer; Estradiol; Estrogen metabolites; Hormonal carcinogenesis

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTRADIOL; ESTROGEN; ESTRONE; 16-HYDROXYESTRONE; 2-HYDROXYESTRONE; ESTRONE DERIVATIVE;

AEROBIC METABOLISM; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; ESTROGEN METABOLISM; GLUCURONIDATION; HUMAN; HYDROXYLATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; REPRODUCIBILITY; REVIEW; RISK REDUCTION; SULFATION; TANDEM MASS SPECTROMETRY; BREAST NEOPLASMS; FEMALE; METABOLISM; PROCEDURES; RISK FACTOR;

BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; EPIDEMIOLOGIC STUDIES; ESTROGENS; FEMALE; HUMANS; HYDROXYESTRONES; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84929842588     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2015.02.015     Document Type: Review

References (47)

1. T. Key, P. Appleby, I. Barnes, G. Reeves Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606 616
2. Endogenous Hormones and Breast Cancer Collaborative Group T.J. Key, P.N. Appleby, G.K. Reeves, R.C. Travis, A.J. Alberg, and A. Barricarte Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies Lancet Oncol 14 2013 1009 1019
3. Endogenous Hormones and Breast Cancer Collaborative Group Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: reanalysis of eighteen prospective studies Steroids 99 2015 49 55
4. W. Yue, J.D. Yager, J.P. Wang, E.R. Jupe, and R.J. Santen Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis Steroids 78 2013 161 170
5. J.D. Yager Mechanisms of estrogen carcinogenesis Steroids 99 2015 56 60
6. R.J. Santen Estrogen metabolites and breast cancer Steroids 99 2015 61 66
7. J. Schneider, D. Kinne, A. Fracchia, V. Pierce, K.E. Anderson, and H.L. Bradlow Abnormal oxidative metabolism of estradiol in women with breast cancer Proc Natl Acad Sci USA 79 1982 3047 3051
8. H.M. Lemon Endocrine influences on human mammary cancer formation. A critique Cancer 23 1969 781 790
9. B. MacMahon, P. Cole, and J. Brown Etiology of human breast cancer: a review J Natl Cancer Inst 50 1973 21 42
10. H.L. Bradlow, D.L. Davis, G. Lin, D. Sepkovic, and R. Tiwari Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk Environ Health Perspect 103 Suppl 7 1995 147 150
11. R.G. Ziegler, S.C. Rossi, T.R. Fears, H.L. Bradlow, H. Adlercreutz, and D. Sepkovic Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine Environ Health Perspect 105 Suppl 3 1997 607 614
12. T.L. Klug, H.L. Bradlow, and D.W. Sepkovic Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16a-hydroxyestrone in urine Steroids 59 1994 648 655
13. H.L. Bradlow, D.W. Sepkovic, T. Klug, and M.P. Osborne Application of an improved ELISA assay to the analysis of urinary estrogen metabolites Steroids 63 1998 406 413
14. R.T. Falk, S.C. Rossi, T.R. Fears, D.W. Sepkovic, A. Migella, and H. Adlercreutz A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid Cancer Epidemiol Biomarkers Prev 9 2000 81 87
15. H.L. Bradlow, H. Jernström, D.W. Sepkovic, T.L. Klug, and S.A. Narod Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites Mol Genet Metab 87 2006 135 146
16. E.N. Meilahn, B. De Stavola, D.S. Allen, I. Fentiman, H.L. Bradlow, and D.W. Sepkovic Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up Br J Cancer 78 1998 1250 1255
17. P. Muti, H.L. Bradlow, A. Micheli, V. Krogh, J.L. Freudenheim, and H.J. Schünemann Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women Epidemiology 11 2000 635 640
18. J.A. Cauley, J.M. Zmuda, M.E. Danielson, B.M. Ljung, D.C. Bauer, and S.R. Cummings Estrogen metabolites and the risk of breast cancer in older women Epidemiology 14 2003 740 744
19. A. Wellejus, A. Olsen, A. Tjonneland, B.L. Thomsen, K. Overvad, and S. Loft Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study Cancer Epidemiol Biomarkers Prev 14 2005 2137 2142
20. A.H. Eliassen, S.A. Missmer, S.S. Tworoger, and S.E. Hankinson Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women Cancer Epidemiol Biomarkers Prev 17 2008 2029 2035
21. A.A. Arslan, R.E. Shore, Y. Afanasyeva, K.L. Koenig, P. Toniolo, and A. Zeleniuch-Jacquotte Circulating estrogen metabolites and risk for breast cancer in premenopausal women Cancer Epidemiol Biomarkers Prev 18 2009 2273 2279
22. R.H. Mackey, T.J. Fanelli, F. Modugno, J.A. Cauley, K.M. McTigue, and M.M. Brooks Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial Cancer Epidemiol Biomarkers Prev 21 2012 2022 2032
23. A.A. Arslan, K.L. Koenig, P. Lenner, Y. Afanasyeva, R.E. Shore, and Y. Chen Circulating estrogen metabolites and risk of breast cancer in postmenopausal women Cancer Epidemiol Biomarkers Prev 23 2014 1290 1297
24. X. Xu, T.D. Veenstra, S.D. Fox, J.M. Roman, H.J. Issaq, and R. Falk Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry Anal Chem 77 2005 6646 6654
25. J.M. Faupel-Badger, B.J. Fuhrman, X. Xu, R.T. Falk, L.K. Keefer, and T.D. Veenstra Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens Cancer Epidemiol Biomarkers Prev 19 2010 292 300
26. X. Xu, J.M. Roman, H.J. Issaq, L.K. Keefer, T.D. Veenstra, and R.G. Ziegler Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry Anal Chem 79 2007 7813 7821
27. B.J. Fuhrman, C. Schairer, M.H. Gail, J. Boyd-Morin, X. Xu, and L.Y. Sue Estrogen metabolism and risk of breast cancer in postmenopausal women J Natl Cancer Inst 104 2012 326 339
28. R.T. Falk, X. Xu, L. Keefer, T.D. Veenstra, and R.G. Ziegler A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability Cancer Epidemiol Biomarkers Prev 17 2008 3411 3418
29. B.J. Fuhrman, X. Xu, R.T. Falk, C.M. Dallal, T.D. Veenstra, and L.K. Keefer Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry Cancer Epidemiol Biomarkers Prev 23 2014 2649 2657
30. H.W. Vesper, J.C. Botelho, M.L. Vidal, Y. Rahmani, L.M. Thienpont, and S.P. Caudill High variability in serum estradiol measurements in men and women Steroids 82 2014 7 13
31. H.W. Vesper, J.C. Botelho, and Y. Wang Challenges and improvements in testosterone and estradiol testing Asian J Androl 16 2014 178 184
32. W. Rosner, S.E. Hankinson, P.M. Sluss, H.W. Vesper, and M.E. Wierman Challenges to the measurement of estradiol: an endocrine society position statement J Clin Endocrinol Metab 98 2013 1376 1387
33. J.S. Lee, B. Ettinger, F.Z. Stanczyk, E. Vittinghoff, V. Hanes, and J.A. Cauley Comparison of methods to measure low serum estradiol levels in postmenopausal women J Clin Endocrinol Metab 91 2006 3791 3797
34. A.H. Eliassen, D. Spiegelman, X. Xu, L.K. Keefer, T.D. Veenstra, and R.L. Barbieri Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women Cancer Res 72 2012 696 706
35. R.T. Falk, L.A. Brinton, J.F. Dorgan, B.J. Fuhrman, T.D. Veenstra, and X. Xu Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study Breast Cancer Res 15 2013 R34
36. C.M. Dallal, J.A. Tice, D.S. Buist, D.C. Bauer, and J.V. Lacey Jr. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B ∼ FIT Carcinogenesis 35 2014 346 355
37. R.G. Ziegler, W.F. Anderson, and M.H. Gail Increasing breast cancer incidence in China: the numbers add up J Natl Cancer Inst 100 2008 1339 1341
38. E. Cavalieri, K. Frenkel, J.G. Liehr, E. Rogan, and D. Roy Estrogens as endogenous genotoxic agents-DNA adducts and mutations J Natl Cancer Inst Monogr 27 2000 75 93
39. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer N Engl J Med 354 2006 270 282
40. H.L. Bradlow, R. Hershcopf, C. Martucci, and J. Fishman 16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer Ann N Y Acad Sci 464 1986 138 151
41. B.T. Zhu, G.Z. Han, J.Y. Shim, Y. Wen, and X.R. Jiang Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding Endocrinology 147 2006 4132 4150
42. S. Kono, G.R. Merriam, D.D. Brandon, D.L. Loriaux, M.B. Lipsett, and T. Fujino Radioimmunoassay and metabolic clearance rate of catecholestrogens, 2-hydroxyestrone and 2-hydroxyestradiol in man J Steroid Biochem 19 1983 627 633
43. E1. Pfeiffer, E. Graf, S. Gerstner, and M. Metzler Stimulation of estradiol glucuronidation: a protective mechanism against estradiol-mediated carcinogenesis? Mol Nutr Food Res 50 2006 385 389
44. L.A. Bransfield, A. Rennie, K. Visvanathan, S.A. Odwin, T.W. Kensler, and J.D. Yager Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine Chem Res Toxicol 21 2008 1622 1630
45. A.H. Eliassen, R.G. Ziegler, B. Rosner, T.D. Veenstra, J.M. Roman, and X. Xu Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women Cancer Epidemiol Biomarkers Prev 18 2009 2860 2868
46. C.E. Matthews, R.T. Fortner, X. Xu, S.E. Hankinson, A.H. Eliassen, and R.G. Ziegler Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women J Clin Endocrinol Metab 97 2012 3724 3733
47. S.S. Tworoger, S.A. Missmer, A.H. Eliassen, R.L. Barbieri, M. Dowsett, and S.E. Hankinson Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women Cancer Causes Control 18 2007 743 752